Capsule Commentary on Tosteson et al., Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium
- PMID: 26857730
- PMCID: PMC4803689
- DOI: 10.1007/s11606-016-3594-5
Capsule Commentary on Tosteson et al., Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium
Comment on
-
Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.J Gen Intern Med. 2016 Apr;31(4):372-9. doi: 10.1007/s11606-015-3552-7. J Gen Intern Med. 2016. PMID: 26658934 Free PMC article.
References
-
- Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D, et al. Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians. 2015;65(1):30–54. - PubMed
-
- Tosteson ANA, Beaber EF, Tiro J, McCarthy AM, Quinn VP, Doria-Rose P, Wheeler CM, Barlow WE, Bronson M, Garcia M, Corley DA, Haas JS, Halm EA, Kamineni A, Rutter CM, Tosteson TD, Trentham-Dietz A, Weaver DL. Variation in screening abnormality rates and follow-up of breast, cervical and colorectal cancer screening within the prospr consortium. J Gen Intern Med. DOI: 10.1007/s11606-015-3552-7. - PMC - PubMed
-
- Centers for Disease Control and Prevention. National Breast and Cervical Cancer Early Detection Program. Retrieved 1/14/2016 from http://www.cdc.gov/cancer/nbccedp/about.htm
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
